Investor Relations

Topic
/home/nadypharcom/public_html/wp-content/themes/monatheme/page-template/template-shareholder.php on line 60

">
                                                    Financial Report(40)
/home/nadypharcom/public_html/wp-content/themes/monatheme/page-template/template-shareholder.php on line 60

">
                                                    Resolution(64)
/home/nadypharcom/public_html/wp-content/themes/monatheme/page-template/template-shareholder.php on line 60

">
                                                    Company Organization and Operation Charter(12)
/home/nadypharcom/public_html/wp-content/themes/monatheme/page-template/template-shareholder.php on line 60

">
                                                    Prospectus(2)
/home/nadypharcom/public_html/wp-content/themes/monatheme/page-template/template-shareholder.php on line 60

">
                                                    Information Disclosure(277)
/home/nadypharcom/public_html/wp-content/themes/monatheme/page-template/template-shareholder.php on line 60

">
                                                    Shareholder News(187)
/home/nadypharcom/public_html/wp-content/themes/monatheme/page-template/template-shareholder.php on line 60

">
                                                    Annual report(16)
Investor Relations

Quan hệ cổ đông
